Yohimbine HCL

All products are provided either as a liquid suspension in a 30mL vial or as raw powder packaged in an individual bag.  5mg/mL solution (150mg/30mL) For More Information Click Here Yohimbine Clinical data Routes ofadministration By mouth ATC code G04BE04 (WHO) QV03AB93 (WHO) Pharmacokinetic data Bioavailability 7-86% (mean 33%) Elimination half-life 0.25-2.5 hours[1] Excretion Urine (as metabolites) Identifiers show IUPAC name CAS Number 146-48-5  PubChem CID 8969 IUPHAR/BPS 102 DrugBank DB01392  ChemSpider 8622  UNII 2Y49VWD90Q KEGG D08685  ChEBI CHEBI:10093  ChEMBL ChEMBL15245  CompTox Dashboard (EPA) DTXSID9040130  ECHA InfoCard 100.005.157  Chemical and physical data Formula C21H26N2O3 Molar mass 354.450 g·mol−1 3D model (JSmol) Interactive image show SMILES show InChI   (verify) **The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. Additionally, it is important to note that research chemicals are intended solely for laboratory study by professional researchers and are not intended for human consumption.**